Advertisement

Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee

      Highlights

      • Patients with heart failure should be offered at least 1 session from a RDN or other health professional with specialist nutrition knowledge for nutritional evaluation and education.
      • DASH or Mediterranean dietary patterns both appear reasonable to recommend for normal-weight patients at risk of heart failure or with established heart failure.
      • At least 5%–10% weight loss is recommended for patients with heart failure and BMI ≥35 kg/m2.
      • For patients identified with malnutrition or cachexia, a goal protein intake of at least 1.1 g·kg−1·d−1 is reasonable.

      ABSTRACT

      Dietary guidance for patients with heart failure (HF) has traditionally focused on sodium and fluid intake restriction, but dietary quality is frequently poor in patients with HF and may contribute to morbidity and mortality. Restrictive diets can lead to inadequate intake of macronutrients and micronutrients by patients with HF, with the potential for deficiencies of calcium, magnesium, zinc, iron, thiamine, vitamins D, E, and K, and folate. Although inadequate intake and low plasma levels of micronutrients have been associated with adverse clinical outcomes, evidence supporting therapeutic repletion is limited. Intravenous iron, thiamine, and coenzyme Q10 have the most clinical trial data for supplementation. There is also limited evidence supporting protein intake goals. Obesity is a risk factor for incident HF, and weight loss is an established approach for preventing HF, with a role for bariatric surgery in patients with severe obesity. However weight loss for patients with existing HF and obesity is a more controversial topic owing to an obesity survival paradox. Dietary interventions and pharmacologic weight loss therapies are understudied in HF populations. There are also limited data for optimal strategies to identify and address cachexia and sarcopenia in patients with HF, with at least 10%–20% of patients with ambulatory systolic HF developing clinically significant wasting. Gaps in our knowledge about nutrition status in patients with HF are outlined in this Statement, and strategies to address the most clinically relevant questions are proposed.

      Key Words

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bozkurt B.
        • Aguilar D.
        • Deswal A.
        • Dunbar S.B.
        • Francis G.S.
        • Horwich T.
        • American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular and Stroke Nursing; Council on Hypertension; Council on Quality and Outcomes Research
        Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association.
        Circulation. 2016; 134: e535-e578
        • Heart Failure Society of America
        Executive summary: HFSA 2010 comprehensive heart failure practice guideline.
        J Card Fail. 2010; 16: 475-539
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • Butler J.
        • Casey D.E.
        • Drazner M.H.
        • et al.
        2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2013; 62: e147-e239
        • Ponikowski P.
        • Voors A.A.
        • Anker S.D.
        • Bueno H.
        • Cleland J.G.F.
        • Coats A.J.S.
        • et al.
        2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
        Eur Heart J. 2016; 37: 2129-2200
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • Butler J.
        • Casey D.E.
        • Colvin M.M.
        • et al.
        2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
        J Card Fail. 2017; 23: 628-651
      1. Heart failure evidence-based nutritional practice guideline.
        Am Acad Nutr Diet. 2017; : 1-34
        • White J.V.
        • Guenter P.
        • Jensen G.
        • Malone A.
        • Schofield M.
        • Academy Malnutrition Work Group; ASPEN Malnutrition Task Force; ASPEN Board of Directors
        Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition.
        JPEN J Parenter Enteral Nutr. 2012; 36: 275-283
        • Jefferson K.
        • Ahmed M.
        • Choleva M.
        • Mak S.
        • Allard J.P.
        • Newton G.E.
        • Arcand J.
        Effect of a sodium-restricted diet on intake of other nutrients in heart failure: implications for research and clinical practice.
        J Card Fail. 2015; 21: 959-962
        • Colin-Ramirez E.
        • McAlister F.A.
        • Zheng Y.
        • Sharma S.
        • Ezekowitz J.A.
        Changes in dietary intake and nutritional status associated with a significant reduction in sodium intake in patients with heart failure. A sub-analysis of the SODIUM-HF pilot study.
        Clin Nutr ESPEN. 2016; 11: e26-e32
        • American Diabetes Association
        Lifestyle management: standards of medical care in diabetes.
        Diabetes Care. 2018; 41: S38-S50
        • Tyson C.C.
        • Nwankwo C.
        • Lin P.-H.
        • Svetkey L.P.
        The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations.
        Curr Hypertens Rep. 2012; 14: 388-396
        • Hummel S.L.
        • Seymour E.M.
        • Brook R.D.
        • Kolias T.J.
        • Sheth S.S.
        • Rosenblum H.R.
        • et al.
        Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction.
        Hypertension. 2012; 60: 1200-1206
        • Hummel S.L.
        • Seymour E.M.
        • Brook R.D.
        • Sheth S.S.
        • Ghosh E.
        • Zhu S.
        • et al.
        Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction.
        Circ Heart Fail. 2013; 6: 1165-1171
        • Mathew A.V.
        • Seymour E.M.
        • Byun J.
        • Pennathur S.
        • Hummel S.L.
        Altered metabolic profile with sodium-restricted dietary approaches to stop hypertension diet in hypertensive heart failure with preserved ejection fraction.
        J Card Fail. 2015; 21: 963-967
        • Levitan E.B.
        • Lewis C.E.
        • Tinker L.F.
        • Eaton C.B.
        • Ahmed A.
        • Manson J.E.
        • et al.
        Mediterranean and DASH diet scores and mortality in women with heart failure: the Women's Health Initiative.
        Circ Heart Fail. 2013; 6: 1116-1123
        • Hummel S.L.
        • Karmally W.
        • Gillespie B.W.
        • Helmke S.
        • Teruya S.
        • Wells J.
        • et al.
        Home-delivered meals post discharge from heart failure hospitalization.
        Circ Heart Fail. 2018; 11e004886
        • Miró Ò.
        • Estruch R.
        • Martín-Sánchez F.J.
        • Gil V.
        • Jacob J.
        • Herrero-Puente P.
        • ICA-SEMES Research Group
        Adherence to Mediterranean diet and all-cause mortality after an episode of acute heart failure: results of the MEDIT-AHF study.
        JACC Heart Fail. 2018; 6: 52-62
        • Sze S.
        • Pellicori P.
        • Kazmi S.
        • Rigby A.
        • Cleland J.G.F.
        • Wong K.
        • Clark A.L.
        Prevalence and prognostic significance of malnutrition using 3 scoring systems among outpatients with heart failure: a comparison with body mass index.
        JACC Heart Fail. 2018; 6: 476-486
        • Aquilani R.
        • Opasich C.
        • Verri M.
        • Boschi F.
        • Febo O.
        • Pasini E.
        • Pastoris O.
        Is nutritional intake adequate in chronic heart failure patients?.
        J Am Coll Cardiol. 2003; 42: 1218-1223
        • Bauer J.
        • Biolo G.
        • Cederholm T.
        • Cesari M.
        • Cruz-Jentoft A.J.
        • Morley J.E.
        • et al.
        Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group.
        J Am Med Dir Assoc. 2013; 14: 542-559
        • Bernstein A.M.
        • Sun Q.
        • Hu F.B.
        • Stampfer M.J.
        • Manson J.E.
        • Willett W.C.
        Major dietary protein sources and risk of coronary heart disease in women.
        Circulation. 2010; 122: 876-883
        • Virtanen H.E.K.
        • Voutilainen S.
        • Koskinen T.T.
        • Mursu J.
        • Tuomainen T.-P.
        • Virtanen J.K.
        Intake of different dietary proteins and risk of heart failure in men.
        Circ Heart Fail. 2018; 11: 1-12
        • Mustafa J.
        • Ellison R.C.
        • Singer M.R.
        • Bradlee M.L.
        • Kalesan B.
        • Holick M.F.
        • Moore L.L.
        Dietary protein and preservation of physical functioning among middle-aged and older adults in the Framingham Offspring Study.
        Am J Epidemiol. 2018; 187: 1411-1419
        • Shetty P.M.
        • Hauptman P.J.
        • Landfried L.K.
        • Patel K.
        • Weiss E.P.
        Micronutrient deficiencies in patients with heart failure: relationships with body mass index and age.
        J Card Fail. 2015; 21: 968-972
        • Song E.K.
        • Kang S.-M.
        Micronutrient deficiency independently predicts adverse health outcomes in patients with heart failure.
        J Cardiovasc Nurs. 2017; 32: 47-53
        • Yoshihisa A.
        • Abe S.
        • Kiko T.
        • Kimishima Y.
        • Sato Y.
        • Watanabe S.
        • et al.
        Association of serum zinc level with prognosis in patients with heart failure.
        J Card Fail. 2018; 24: 375-383
        • Lennie T.A.
        • Andreae C.
        • Rayens M.K.
        • Song E.K.
        • Dunbar S.B.
        • Pressler S.J.
        • et al.
        Micronutrient deficiency independently predicts time to event in patients with heart failure.
        J Am Heart Assoc. 2018; e007251
        • McKeag N.A.
        • McKinley M.C.
        • Harbinson M.T.
        • Noad R.L.
        • Dixon L.H.
        • McGinty A.
        • et al.
        The effect of multiple micronutrient supplementation on left ventricular ejection fraction in patients with chronic stable heart failure: a randomized, placebo-controlled trial.
        JACC Heart Fail. 2014; 2: 308-317
        • Jain A.
        • Mehta R.
        • Al-Ani M.
        • Hill J.A.
        • Winchester D.E.
        Determining the role of thiamine deficiency in systolic heart failure: a meta-analysis and systematic review.
        J Card Fail. 2015; 21: 1000-1007
        • Fotino A.D.
        • Thompson-Paul A.M.
        • Bazzano L.A.
        Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis.
        Am J Clin Nutr. 2013; 97: 268-275
        • Mortensen S.A.
        • Rosenfeldt F.
        • Kumar A.
        • Dolliner P.
        • Filipiak K.J.
        • Pella D.
        • Q-SYMBIO Study Investigators
        The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
        JACC Heart Fail. 2014; 2: 641-649
        • Aune D.
        • Sen A.
        • Norat T.
        • Janszky I.
        • Romundstad P.
        • Tonstad S.
        • Vatten L.J.
        Body mass index, abdominal fatness and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies.
        Circulation. 2016; 133: 639-649
        • Pandey A.
        • LaMonte M.
        • Klein L.
        • Ayers C.
        • Psaty B.M.
        • Eaton C.B.
        • et al.
        Relationship between physical activity, body mass index, and risk of heart failure.
        J Am Coll Cardiol. 2017; 69: 1129-1142
        • del Gobbo L.C.
        • Kalantarian S.
        • Imamura F.
        • Lemaitre R.
        • Siscovick D.S.
        • et al.
        Contribution of major lifestyle risk factors for incident heart failure in older adults: the Cardiovascular Health Study.
        JACC Heart Fail. 2015; 3: 520-528
        • Ebong I.A.
        • Goff Jr, D.C.
        • Rodriguez C.J.
        • Chen H.
        • Bluemke D.
        • Szklo M.
        • Bertoni A.G.
        The relationship between measures of obesity and incident heart failure: the Multi-Ethnic Study of Atherosclerosis.
        Obesity. 2013; 21: 1915-1922
        • Pandey A.
        • Cornwell W.K.
        • Willis B.
        • Neeland I.J.
        • Gao A.
        • Leonard D.
        • et al.
        Body mass index and cardiorespiratory fitness in mid-life and risk of heart failure hospitalization in older age: findings from the Cooper Center Longitudinal Study.
        JACC Heart Fail. 2017; 5: 367-374
        • Carbone S.
        • Lavie C.J.
        • Arena R.
        Obesity and heart failure: focus on the obesity paradox.
        Mayo Clin Proc. 2017; 92: 266-279
        • Kharod A.M.
        • Ramlogan S.R.
        • Kumar S.
        • Raghuveer T.
        • Drake W.
        • Dai H.
        • Raghuveer G.
        Childhood obesity increases left-ventricular mass irrespective of blood pressure status.
        Pediatr Cardiol. 2013; 35: 353-360
        • Gadde K.M.
        • Martin C.K.
        • Berthoud H.-R.
        • Heymsfield S.B.
        Obesity.
        J Am Coll Cardiol. 2018; 71: 69-84
        • Jensen M.D.
        • Ryan D.H.
        • Apovian C.M.
        • Ard J.D.
        • Comuzzie A.G.
        • Donato K.A.
        • American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society
        2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society.
        Circulation. 2014; 129: S102-S138
        • Aggarwal M.
        • Bozkurt B.
        • Panjrath G.
        • Aggarwal B.
        • Ostfeld R.J.
        • Barnard N.D.
        • et al.
        Lifestyle modifications for preventing and treating heart failure.
        J Am Coll Cardiol. 2018; 72: 2391-2405
        • Fothergill E.
        • Guo J.
        • Howard L.
        • Kerns J.C.
        • Knuth N.D.
        Persistent metabolic adaptation 6 years after “The Biggest Loser” competition.
        Obes Biol Integr Physiol. 2016; 24: 1612-1619
        • Levitan E.B.
        • Wolk A.
        • Mittleman M.A.
        Consistency with the DASH diet and incidence of heart failure.
        Arch Intern Med. 2009; 169: 851-857
        • Nettleton J.A.
        • Steffen L.M.
        • Loehr L.R.
        • Rosamond W.D.
        • Folsom A.R.
        Incident heart failure is associated with lower whole-grain intake and greater high-fat dairy and egg intake in the Atherosclerosis Risk in Communities (ARIC) study.
        J Am Diet Assoc. 2008; 108: 1881-1887
        • Rautiainen S.
        • Levitan E.B.
        • Mittleman M.A.
        • Wolk A.
        Fruit and vegetable intake and rate of heart failure: a population‐based prospective cohort of women.
        Eur J Heart Fail. 2015; 17: 20-26
        • Papadaki A.
        • Martínez-González M.Á.
        • Alonso-Gómez A.
        • Rekondo J.
        • Salas-Salvadó J.
        • Corella D.
        • et al.
        Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial.
        Eur J Heart Fail. 2017; 19: 1179-1185
        • Look AHEAD Research Group
        Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
        N Engl J Med. 2013; 369: 145-154
        • Sacks F.M.
        • Bray G.A.
        • Carey V.J.
        • Smith S.R.
        • Ryan D.H.
        • Anton S.D.
        • et al.
        Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.
        N Engl J Med. 2009; 360: 859-873
        • Tobias D.K.
        • Chen M.
        • Manson J.E.
        • Ludwig D.S.
        • Willett W.
        • Hu F.B.
        Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis.
        Lancet Diabetes Endocrinol. 2015; 3: 968-979
        • Ebbeling C.B.
        • Feldman H.A.
        • Klein G.L.
        • Wong J.M.W.
        • Bielak L.
        • Steltz S.K.
        • et al.
        Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial.
        Br Med J. 2018; 363: k4583
        • Shai I.
        • Schwarzfuchs D.
        • Henkin Y.
        • Shahar D.R.
        • Witkow S.
        • Greenberg I.
        • For the Dietary Intervention Randomized Controlled Trial (DIRECT) Group
        Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.
        N Engl J Med. 2008; 359: 229-241
        • Coleman C.D.
        • Kiel J.R.
        • Mitola A.H.
        • Langford J.S.
        • Davis K.N.
        • Arterburn L.M.
        Effectiveness of a Medifast meal replacement program on weight, body composition and cardiometabolic risk factors in overweight and obese adults: a multicenter systematic retrospective chart review study.
        Nutr J. 2015; 14: 77
        • Apovian C.M.
        • Aronne L.J.
        • Bessesen D.H.
        • McDonnell M.E.
        • Murad M.H.
        • Pagotto U.
        • et al.
        Pharmacological management of obesity: an Endocrine Society clinical practice guideline.
        J Clin Endocrinol Metab. 2015; 100: 342-362
        • Pi-Sunyer X.
        • Astrup A.
        • Fujioka K.
        • Greenway F.
        • Halpern A.
        • Krempf M.
        • SCALE Obesity and Prediabetes NN8022-1839 Study Group
        A randomized, controlled trial of 3.0 mg of liraglutide in weight management.
        N Engl J Med. 2015; 373: 11-22
        • Marso S.P.
        • Daniels G.H.
        • Brown-Frandsen K.
        • Kristensen P.
        • Mann J.F.E.
        • Nauck M.A.
        • et al.
        Liraglutide and cardiovascular outcomes in type 2 diabetes.
        N Engl J Med. 2016; 375: 311-322
        • Bohula E.A.
        • Wiviott S.D.
        • McGuire D.K.
        • Inzucchi S.E.
        • Kuder J.
        • Im K.
        • et al.
        Cardiovascular safety of lorcaserin in overweight or obese patients.
        N Engl J Med. 2018; 379: 1107-1117
        • Adams T.D.
        • Davidson L.E.
        • Litwin S.E.
        • Kim J.
        • Kolotkin R.L.
        • Nanjee M.N.
        • et al.
        Weight and metabolic outcomes 12 years after gastric bypass.
        N Engl J Med. 2017; 377: 1143-1155
        • Mechanick J.I.
        • Youdim A.
        • Jones D.B.
        • Garvey W.T.
        • Hurley D.L.
        • McMahon M.M.
        • American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic and Bariatric Surgery
        Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic and Bariatric Surgery.
        Obesity. 2013; 21: S1-27
        • Netto B.D.M.
        • Bettini S.C.
        • Clemente A.P.G.
        • de Carvalho Ferreira J.P.
        • Boritza K.
        • de Fátima Souza S.
        • et al.
        Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity.
        Obes Surg. 2014; 25: 1010-1018
        • Vest A.R.
        • Heneghan H.M.
        • Agarwal S.
        • Schauer P.R.
        • Young J.B.
        Bariatric surgery and cardiovascular outcomes: a systematic review.
        Heart. 2012; 98: 1763-1777
        • Aggarwal R.
        • Harling L.
        • Efthimiou E.
        • Darzi A.
        • Athanasiou T.
        • Ashrafian H.
        The effects of bariatric surgery on cardiac structure and function: a systematic review of cardiac imaging outcomes.
        Obes Surg. 2015; 26: 1030-1040
        • Sundström J.
        • Bruze G.
        • Ottosson J.
        • Marcus C.
        • Näslund I.
        • Neovius M.
        Weight loss and heart failure: a nationwide study of gastric bypass surgery versus intensive lifestyle treatment.
        Circulation. 2017; 135: 1577-1585
        • Benotti P.N.
        • Wood G.C.
        • Carey D.J.
        • Mehra V.C.
        • Mirshahi T.
        • Lent M.R.
        • et al.
        Gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long-term risks of congestive heart failure.
        J Am Heart Assoc. 2017; 6e005126
        • Persson C.E.
        • Björck L.
        • Lagergren J.
        • Lappas G.
        • Giang K.W.
        • Rosengren A.
        Risk of heart failure in obese patients with and without bariatric surgery in Sweden—a registry-based study.
        J Card Fail. 2017; 23: 530-537
        • Joyce E.
        • Lala A.
        • Stevens S.R.
        • Cooper L.B.
        • AbouEzzeddine O.F.
        • Groarke J.D.
        • et al.
        Heart Failure Apprentice Network. Prevalence, profile, and prognosis of severe obesity in contemporary hospitalized heart failure trial populations.
        JACC Heart Fail. 2016; 4: 923-931
        • Ndumele C.E.
        • Matsushita K.
        • Sang Y.
        • Lazo M.
        • Agarwal S.K.
        • Nambi V.
        • et al.
        N-Terminal pro–brain natriuretic peptide and heart failure risk among individuals with and without obesity: the Atherosclerosis Risk in Communities (ARIC) study.
        Circulation. 2016; 133: 631-638
        • Daniels L.B.
        • Clopton P.
        • Bhalla V.
        • Krishnaswamy P.
        • Nowak R.M.
        • McCord J.
        • et al.
        How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly multinational study.
        Am Heart J. 2006; 151: 999-1005
        • Frankenstein L.
        • Remppis A.
        • Nelles M.
        • Schaelling B.
        • Schellberg D.
        • Katus H.
        • Zugck C.
        Relation of N-terminal pro–brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status.
        Eur Heart J. 2008; 29: 2634-2640
        • Clark A.L.
        • Fonarow G.C.
        • Horwich T.B.
        Obesity and the obesity paradox in heart failure.
        Prog Cardiovasc Dis. 2014; 56: 409-414
        • Padwal R.
        • McAlister F.A.
        • McMurray J.J.V.
        • Cowie M.R.
        • Rich M.
        • Pocock S.
        • Meta-Analysis Global Group In Chronic Heart Failure (MAGGIC)
        The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data.
        Int J Obes Relat Metab Disord. 2014; 38: 1110-1114
        • Charnigo R.
        • Guglin M.
        Obesity paradox in heart failure: statistical artifact, or impetus to rethink clinical practice?.
        Heart Fail Rev. 2016; 22: 13-23
        • O'Brien E.C.
        • Thomas L.E.
        Untangling the paradox: obesity as prognostic marker in prevalent cardiovascular disease.
        Am Heart J. 2016; 172: 170-172
        • Mehra M.R.
        • Canter C.E.
        • Hannan M.M.
        • Semigran M.J.
        • Uber P.A.
        • Baran D.A.
        • et al.
        The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update.
        J Heart Lung Transplant. 2016; 35: 1-23
        • Trepanowski J.F.
        • Kroeger C.M.
        • Barnosky A.
        • Klempel M.C.
        • Bhutani S.
        • Hoddy K.K.
        • et al.
        Effect of alternate-day fasting on weight loss, weight maintenance, and cardioprotection among metabolically healthy obese adults: a randomized clinical trial.
        JAMA Intern Med. 2017; 177: 930-938
        • Khera R.
        • Murad M.H.
        • Chandar A.K.
        • Dulai P.S.
        • Wang Z.
        • Prokop L.J.
        • et al.
        Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis.
        JAMA. 2016; 315: 2424-2434
        • Beck-da-Silva L.
        • Higginson L.
        • Fraser M.
        • Williams K.
        • Haddad H.
        Effect of orlistat in obese patients with heart failure: a pilot study.
        Congest Heart Fail. 2005; 11: 118-123
        • Jordan J.
        • Astrup A.
        • Engeli S.
        • Narkiewicz K.
        • Day W.W.
        • Finer N.
        Cardiovascular effects of phentermine and topiramate.
        J Hypertens. 2014; 32: 1178-1188
        • Weissman N.J.
        • Sanchez M.
        • Koch G.G.
        • Smith S.R.
        • Shanahan W.R.
        • Anderson C.M.
        Echocardiographic assessment of cardiac valvular regurgitation with lorcaserin from analysis of 3 phase 3 clinical trials.
        Circ Cardiovasc Imaging. 2013; 6: 560-567
        • Nissen S.E.
        • Wolski K.E.
        • Prcela L.
        • Wadden T.
        • Buse J.B.
        • Bakris G.
        • et al.
        Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors.
        JAMA Intern Med. 2016; 315: 990-1004
        • Margulies K.B.
        • Hernandez A.F.
        • Redfield M.M.
        • Givertz M.M.
        • Oliveira G.H.
        • Cole R.
        • National Heart, Lung, and Blood Institute Heart Failure Clinical Research Network
        Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial.
        JAMA. 2016; 316: 500-508
        • Vest A.R.
        • Patel P.
        • Schauer P.R.
        • Satava M.E.
        • Cavalcante J.L.
        • Brethauer S.
        • Young J.B.
        Clinical and echocardiographic outcomes after bariatric surgery in obese patients with left ventricular systolic dysfunction.
        Circ Heart Fail. 2016; 9e002260
        • Shimada Y.J.
        • Tsugawa Y.
        • Brown D.F.M.
        • Hasegawa K.
        Bariatric surgery and emergency department visits and hospitalizations for heart failure exacerbation: population-based, self-controlled series.
        J Am Coll Cardiol. 2015; 67: 895-903
        • Shah S.K.
        • Gregoric I.D.
        • Nathan S.S.
        • Akkanti B.H.
        • Kar B.
        • Bajwa K.S.
        Simultaneous left ventricular assist device placement and laparoscopic sleeve gastrectomy as a bridge to transplant for morbidly obese patients with severe heart failure.
        J Heart Lung Transplant. 2015; 34: 1489-1491
        • Lim C.-P.
        • Fisher O.M.
        • Falkenback D.
        • Boyd D.
        • Hayward C.S.
        • Keogh A.
        • et al.
        Bariatric surgery provides a “bridge to transplant” for morbidly obese patients with advanced heart failure and may obviate the need for transplantation.
        Obes Surg. 2016; 26: 486-493
        • Fülster S.
        • Tacke M.
        • Sandek A.
        • Ebner N.
        • Tschöpe C.
        • Doehner W.
        • et al.
        Muscle wasting in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
        Eur Heart J. 2013; 34: 512-519
        • Greene S.J.
        • Vaduganathan M.
        • Lupi L.
        • Ambrosy A.P.
        • Mentz R.J.
        • Konstam M.A.
        • EVEREST Trial Investigators
        Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST trial).
        Am J Cardiol. 2013; 111: 574-581
        • Kato T.S.
        • Kitada S.
        • Yang J.
        • Wu C.
        • Takayama H.
        • Naka Y.
        • Farr M.
        • et al.
        Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation.
        Am J Cardiol. 2013; 112: 1484-1488
        • Mebazaa A.
        • Gayat E.
        • Lassus J.
        • Meas T.
        • Mueller C.
        • Maggioni A.
        • et al.
        Association between elevated blood glucose and outcome in acute heart failure.
        J Am Coll Cardiol. 2013; 61: 820-829
        • Evans W.J.
        • Morley J.E.
        • Argilés J.
        • Bales C.
        • Baracos V.
        • Guttridge D.
        • et al.
        Cachexia: a new definition.
        Clin Nutr. 2008; 27: 793-799
        • von Haehling S.
        • Ebner N.
        • Dos Santos M.R.
        • Springer J.
        • Anker S.D.
        Muscle wasting and cachexia in heart failure: mechanisms and therapies.
        Nat Rev Cardiol. 2017; 14: 323-341
        • Dent E.
        • Morley J.E.
        • Cruz-Jentoft A.J.
        • Arai H.
        • Kritchevsky S.B.
        • Guralnik J.
        • et al.
        International Clinical Practice Guidelines for Sarcopenia (ICFSR): screening, diagnosis and management.
        J Nutr Health Aging. 2018; 22: 1148-1161
        • Cruz-Jentoft A.J.
        • Bahat G.
        • Bauer J.
        • Boirie Y.
        • Bruyère O.
        • Cederholm T.
        • Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2); Extended Group for EWGSOP2
        Sarcopenia: revised European consensus on definition and diagnosis.
        Age Ageing. 2019; 48: 16-31
        • Emami A.
        • Saitoh M.
        • Valentova M.
        • Sandek A.
        • Evertz R.
        • Ebner N.
        • et al.
        Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
        Eur J Heart Fail. 2018; 1: 4
        • Christensen H.M.
        • Kistorp C.
        • Schou M.
        • Keller N.
        • Zerahn B.
        • Frystyk J.
        • et al.
        Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status.
        Endocrine. 2012; 43: 626-634
        • Hajahmadi M.
        • Shemshadi S.
        • Khalilipur E.
        • Amin A.
        • Taghavi S.
        • Maleki M.
        • et al.
        Muscle wasting in young patients with dilated cardiomyopathy.
        J Cachexia Sarcopenia Muscle. 2017; 8: 542-548
        • Russo M.J.
        • Hong K.N.
        • Davies R.R.
        • Chen J.M.
        • Mancini D.M.
        • Oz M.C.
        • et al.
        The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines?.
        Ann Surg. 2010; 251: 144-152
        • Alves F.D.
        • Souza G.C.
        • Biolo A.
        • Clausell N.
        Comparison of two bioelectrical impedance devices and dual-energy x-ray absorptiometry to evaluate body composition in heart failure.
        J Hum Nutr Diet. 2014; 27: 632-638
        • Heberton G.A.
        • Nassif M.
        • Bierhals A.
        • Novak E.
        • LaRue S.J.
        • Lima B.
        • et al.
        Usefulness of psoas muscle area determined by computed tomography to predict mortality or prolonged length of hospital stay in patients undergoing left ventricular assist device implantation.
        Am J Cardiol. 2016; 118: 1363-1367
        • Teigen L.M.
        • John R.
        • Kuchnia A.J.
        • Nagel E.M.
        • Earthman C.P.
        • Kealhofer J.
        • et al.
        Preoperative pectoralis muscle quantity and attenuation by computed tomography are novel and powerful predictors of mortality after left ventricular assist device implantation.
        Circ Heart Fail. 2017; 10e004069
        • Loncar G.
        • Springer J.
        • Anker M.
        • Doehner W.
        • Lainscak M.
        Cardiac cachexia: hic et nunc.
        J Cachexia Sarcopenia Muscle. 2016; 7: 246-260
        • Kaneko H.
        • Suzuki S.
        • Goto M.
        • Yuzawa Y.
        • Arita T.
        • Yagi N.
        • et al.
        Geriatric nutritional risk index in hospitalized heart failure patients.
        Int J Cardiol. 2015; 181: 213-215
        • Khan R.S.
        • Kato T.S.
        • Chokshi A.
        • Chew M.
        • Yu S.
        • Wu C.
        • et al.
        Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation.
        Circ Heart Fail. 2012; 5: 340-348
        • Vest A.R.
        • Mistak S.M.
        • Hachamovitch R.
        • Mountis M.M.
        • Moazami N.
        • Young J.B.
        Outcomes for patients with diabetes after continuous-flow left ventricular assist device implantation.
        J Card Fail. 2016; 22: 789-796
        • Vest A.R.
        • Kennel P.J.
        • Maldonado D.
        • Young J.B.
        • Mountis M.M.
        • Naka Y.
        • et al.
        Recovery of serum cholesterol predicts survival after left ventricular assist device implantation.
        Circ Heart Fail. 2016; 9e002881
        • Ahmad T.
        • Wang T.
        • O'Brien E.C.
        • Samsky M.D.
        • Pura J.A.
        • Lokhnygina Y.
        • et al.
        Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury.
        JACC Heart Fail. 2015; 3: 30-39
        • Emani S.
        • Brewer R.J.
        • John R.
        • Slaughter M.S.
        • Lanfear D.E.
        • Ravi Y.
        • Sundareswaran K.S.
        • et al.
        Patients with low compared with high body mass index gain more weight after implantation of a continuous-flow left ventricular assist device.
        J Heart Lung Transplant. 2013; 32: 31-35
        • Ahmad T.
        • Kelly J.P.
        • McGarrah R.W.
        • Hellkamp A.S.
        • Fiuzat M.
        • Testani J.M.
        • et al.
        Prognostic implications of long-chain acylcarnitines in heart failure and reversibility with mechanical circulatory support.
        J Am Coll Cardiol. 2016; 67: 291-299
        • Bonilla-Palomas J.L.
        • Gámez-López A.L.
        • Castillo-Domínguez J.C.
        • Moreno-Conde M.
        • López-Ibáñez M.C.
        • Alhambra-Expósito R.
        • et al.
        Nutritional intervention in malnourished hospitalized patients with heart failure.
        Arch Med Res. 2016; 47: 535-540
        • Wu C.
        • Kato T.S.
        • Ji R.
        • Zizola C.
        • Brunjes D.L.
        • Deng Y.
        • et al.
        Supplementation of l-alanyl-l-glutamine and fish oil improves body composition and quality of life in patients with chronic heart failure.
        Circ Heart Fail. 2015; 8: 1077-1087
        • Temel J.S.
        • Abernethy A.P.
        • Currow D.C.
        • Friend J.
        • Duus E.M.
        • Yan Y.
        • Fearon K.C.
        Anamorelin in patients with nonsmall-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.
        Lancet Oncol. 2016; 17: 519-531
        • Pineda-Juárez J.A.
        • Sánchez-Ortiz N.A.
        • Castillo-Martinez L.
        • Orea-Tejeda A.
        • Cervantes-Gaytán R.
        • Keirns-Davis C.
        • et al.
        Changes in body composition in heart failure patients after a resistance exercise program and branched chain amino acid supplementation.
        Clin Nutr. 2016; 35: 41-47
        • Giuliano C.
        • Karahalios A.
        • Neil C.
        • Allen J.
        • Levinger I.
        The effects of resistance training on muscle strength, quality of life and aerobic capacity in patients with chronic heart failure—a meta-analysis.
        Int J Cardiol. 2017; 227: 413-423
        • Tzanis G.
        • Philippou A.
        • Karatzanos E.
        • Dimopoulos S.
        • Kaldara E.
        • Nana E.
        • et al.
        Effects of high-intensity interval exercise training on skeletal myopathy of chronic heart failure.
        J Card Fail. 2017; 23: 36-46
        • Piercy K.L.
        • Troiano R.P.
        • Ballard R.M.
        • Carlson S.A.
        • Fulton J.E.
        • Galuska D.A.
        • et al.
        The Physical Activity Guidelines for Americans.
        JAMA. 2018; 320: 2020-2028
        • McClave S.A.
        • Taylor B.E.
        • Martindale R.G.
        • Warren M.M.
        • Johnson D.R.
        • Braunschweig C.
        • Society of Critical Care Medicine; American Society for Parenteral and Enteral Nutrition
        Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).
        JPEN J Parenter Enteral Nutr. 2016; 40: 159-211
        • Weimann A.
        • Braga M.
        • Carli F.
        • Higashiguchi T.
        • Hübner M.
        • Klek S.
        • et al.
        ESPEN guideline: clinical nutrition in surgery.
        Clin Nutr. 2017; 36: 623-650
        • Evangelista L.S.
        • Heber D.
        • Li Z.
        • Bowerman S.
        • Hamilton M.A.
        • Fonarow G.C.
        Reduced body weight and adiposity with a high-protein diet improves functional status, lipid profiles, glycemic control, and quality of life in patients with heart failure: a feasibility study.
        J Cardiovasc Nurs. 2009; 24: 207-215
        • O'Connor C.M.
        • Whellan D.J.
        • Lee K.L.
        • Keteyian S.J.
        • Cooper L.S.
        • Ellis S.J.
        • et al.
        • for the HF-ACTION Investigators. (HF-ACTION=Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training)
        Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
        JAMA. 2009; 301: 1439-1450
        • Horwich T.B.
        • Broderick S.
        • Chen L.
        • McCullough P.A.
        • Strzelczyk T.
        • Kitzman D.W.
        • et al.
        Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure.
        Am J Cardiol. 2011; 108: 1754-1759
        • Pritchett A.M.
        • Deswal A.
        • Aguilar D.
        • Foreyt J.P.
        • Chan W.
        • Mann D.L.
        • et al.
        Lifestyle modification with diet and exercise in obese patients with heart failure—a pilot study.
        J Obes Weight Loss Ther. 2012; 2: 1-8
        • Ritzel A.
        • Otto F.
        • Bell M.
        • Sabin G.
        • Wieneke H.
        Impact of lifestyle modification on left ventricular function and cardiopulmonary exercise capacity in patients with heart failure with normal ejection fraction and cardiometabolic syndrome: a prospective interventional study.
        Acta Cardiol. 2015; 70: 43-50
        • Kitzman D.W.
        • Brubaker P.
        • Morgan T.
        • Haykowsky M.
        • Hundley G.
        • Kraus W.E.
        • et al.
        Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial.
        JAMA. 2016; 315: 36-46
        • González-Islas D.
        • Orea-Tejeda A.
        • Castillo-Martinez L.
        • Olvera-Mayorga G.
        • Rodríguez-García W.D.
        • Santillán-Díaz C.
        • et al.
        The effects of a low-carbohydrate diet on oxygen saturation in heart failure patients: a randomized controlled clinical trial.
        Nutr Hosp. 2017; 34: 792-798